Tag: IATI

Israel’s biomed industry is in full bloom; Don’t believe us? Let the numbers speak for themselves! Here are some stats that paint a quick picture of the industry growth: 1,380: the number of active biomed companies in the Startup Nation, an all-time high. 280: the number of R&D centers operating in Israel for foreign companies, including healthcare, for example: Johnson & Johnson, Philips, General Electric, Merck Serono, Abbott. $801 million: the amount raised from venture capital firms in 2014, which was 24% of all VC investments, showing recovery since the 2008/9 financial crisis. $2.9B: total sum of Israeli life science company acquisitions in 2013-14. Earlier this week, IATI released the 2015 Israel Life Sciences Industry Report that, in addition to the above-mentioned data, outlines the state of the biomed industry in the Startup Nation, including the investment landscape. OurCrowd is rated the “second most active life sciences investor in 2014,” right after VC firm OrbiMedIsrael Partners. With medtech encompassing 21% of OurCrowd’s investment portfolio, it would seem we are in line with the greater VC ecosystem in Israel. This indeed calls for a celebration. Luckily, it just so...